J&J vaccine gets conditional approval and Pfizer trial shows great success
The J&J vaccine can now start being used in the general population, while the Pfizer trial shows its vaccine is effective against the B.1.351 variant
01 April 2021 - 15:40
UPDATED 01 April 2021 - 18:34
Johnson & Johnson (J&J) has announced that its single-dose vaccine, being used in a clinical trial for health workers, has received approval for use in SA.
SA Health Products Regulatory Authority (Sahpra) CEO Boitumelo Semete-Makokotlela said, “The registration signals a significant step in the fight against the Covid-19 pandemic.”..
BL Premium
This article is reserved for our subscribers.
A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Sunday Times Daily.
Already subscribed? Simply sign in below.
Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now